Common use of INVESTIGATIONAL PRODUCTS Clause in Contracts

INVESTIGATIONAL PRODUCTS. 7.1. Parties acknowledge and agree that the Institution’s pharmacist, or such other pharmacist as appointed by Sponsor the Principal Investigator and the Institution, will be responsible for certain tasks in relation with the handling of the Investigational Product. Any agreements between the pharmacist and any of the Parties will be in writing and must be in accordance with the Institution’s internal policies. Any such agreements will be annexed to this Agreement as Annex 4. 7.2. Subject to the foregoing, the Sponsor will provide the Principal Investigator and the pharmacist with all necessary information on the Investigational Product(s), quality and handling instructions thereof and sufficient quantities needed to conduct the Clinical Trial. 7.3. The Principal Investigator shall not use or permit the Research Staff or any third party to use the Investigational Product for any purpose other than the conduct of the Clinical Trial and upon termination or expiration of this Agreement all unused Investigational Product shall, at the Sponsor’s option, either be returned to the Sponsor or disposed of in accordance with the Protocol or the Sponsor’s written instructions. 7.4. In case Sponsor has provided any equipment, such equipment to be further described in Annex 5 attached to this Agreement, to Institution or the Principal Investigator for the conduct of the Clinical Trial at the Trial Site, such equipment shall remain the property of Sponsor and shall be treated in accordance with the provisions as described in more detail in said Annex 5.

INVESTIGATIONAL PRODUCTS. 7.1. Parties acknowledge and agree that the Institution’s pharmacist, or such other pharmacist as appointed by Sponsor the Principal Investigator and the Institution, will be responsible for certain tasks in relation with the handling of the Investigational Product. Any agreements between the pharmacist and any of the Parties will be in writing and must be in accordance with the Institution’s internal policies. Any such agreements will be annexed to this Agreement as Annex 4. 7.2. Subject to the foregoing, the Sponsor will provide the Principal Investigator and the pharmacist with all necessary information on the Investigational Product(s), quality and handling instructions thereof and sufficient quantities needed to conduct the Clinical Trial. 7.3. The Principal Investigator shall not use or permit the Research Staff or any third party to use the Investigational Product for any purpose other than the conduct of the Clinical Trial and upon termination or expiration of this Agreement all unused Investigational Product shall, at the Sponsor’s option, either be returned to the Sponsor or disposed of in accordance with the Protocol or the Sponsor’s written instructions. 7.4. In case Sponsor has provided any equipment, such equipment to be further described in Annex 5 attached to this Agreement, to Institution or the Principal Investigator for the conduct of the Clinical Trial at the Trial Site, such equipment shall remain the property of Sponsor and shall be treated in accordance with the provisions as described in more detail in said Annex 5.